The Shareholders Foundation announces that an investigation on behalf of investors of Vascular Solutions, Inc. (NASDAQ:VASC) shares was launched over potential securities laws violations by Vascular Solutions and certain of its directors and officers.
Investors who purchased shares of Vascular Solutions, Inc. (NASDAQ:VASC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Vascular Solutions, Inc. (NASDAQ:VASC) concerning whether a series of statements by Vascular Solutions regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On November 13, 2014, a federal grand jury indicted Vascular Solutions’ CEO, Howard Root, on charges he conspired to sell a varicose-vein treatment device for unapproved uses. The nine count indictment alleges Vascular Solutions, Inc improperly marketed its Vri-Lase device kit for use on veins deep in the leg, even though it was only approved for use on superficial blood vessels and a clinical trial showed adverse events when Vari-Lase was used on deeper veins. Shares of Vascular Solutions, Inc dropped from almost $31 per share on November 13, 2014, to as low as $23.23 per share on November 13, 2014.
On November 28, 2014, NASDAQ:VASC shares closed at $25.72 per share.
Those who purchased shares of Vascular Solutions, Inc. have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com